Rasagiline
NDC 64980-711, Rasagiline mesylate, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 64980-711
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218163
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64980-711 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RASAGILINE MESYLATE.5 mg/1
Pharmacologic classes
Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64980-711-30 | 64980071130 | 30 TABLET in 1 BOTTLE (64980-711-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7d9eac3f-7441-45cf-a603-ea18c116e2c0NADAC price for package 64980071130
GET /v1/drugs/nadac/64980071130
Use it
Look up 64980-711 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64980-711 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64980-711. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.